These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 33687591)

  • 1. A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus.
    Gong JN; Zhao L; Chen G; Chen X; Chen ZD; Chen CY
    Mol Divers; 2021 Aug; 25(3):1375-1393. PubMed ID: 33687591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening of dipeptidyl peptidase-4 inhibitors using quantitative structure-activity relationship-based artificial intelligence and molecular docking of hit compounds.
    Hermansyah O; Bustamam A; Yanuar A
    Comput Biol Chem; 2021 Dec; 95():107597. PubMed ID: 34800858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms.
    He X; Zhao L; Zhong W; Chen HY; Shan X; Tang N; Chen CY
    Biomed Pharmacother; 2020 Sep; 129():110360. PubMed ID: 32559623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More effective DPP4 inhibitors as antidiabetics based on sitagliptin applied QSAR and clinical methods.
    Buiu C; Avram S; Duda-Seiman D; Milac AL; Duda-Seiman C; Pacureanu L; Borcan F
    Curr Comput Aided Drug Des; 2014; 10(3):237-49. PubMed ID: 25756669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of levomenthol derivatives as potential dipeptidyl peptidase-4 inhibitors: a comparative study with gliptins.
    Alade AA; Ahmed SA; Mujwar S; Kikiowo B; Akinnusi PA; Olubode SO; Olufemi OM; Ohilebo AA
    J Biomol Struct Dyn; 2024 May; 42(8):4029-4047. PubMed ID: 37261796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.
    Shoombuatong W; Prachayasittikul V; Anuwongcharoen N; Songtawee N; Monnor T; Prachayasittikul S; Prachayasittikul V; Nantasenamat C
    Drug Des Devel Ther; 2015; 9():4515-49. PubMed ID: 26309399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
    Meduru H; Wang YT; Tsai JJ; Chen YC
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational approaches for lead compound discovery in dipeptidyl peptidase-4 inhibition using machine learning and molecular dynamics techniques.
    De La Torre S; Cuesta SA; Calle L; Mora JR; Paz JL; Espinoza-Montero PJ; Flores-Sumoza M; Márquez EA
    Comput Biol Chem; 2024 Oct; 112():108145. PubMed ID: 39002224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
    Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
    Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Molecular Insights into the Inhibition of Dipeptidyl Peptidase-4 by Natural Cyclic Peptide Oxytocin.
    Chittepu VCSR; Kalhotra P; Osorio-Gallardo T; Jiménez-Martínez C; Torre RRR; Gallardo-Velazquez T; Osorio-Revilla G
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31661941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
    Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
    J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dipeptidyl peptidase 4 inhibitory peptides from Largemouth bass (Micropterus salmoides) by a comprehensive approach.
    Wang K; Yang X; Lou W; Zhang X
    Bioorg Chem; 2020 Dec; 105():104432. PubMed ID: 33157343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies.
    Abd El-Karim SS; Anwar MM; Syam YM; Nael MA; Ali HF; Motaleb MA
    Bioorg Chem; 2018 Dec; 81():481-493. PubMed ID: 30243239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbolic relational graph convolution networks plus: a simple but highly efficient QSAR-modeling method.
    Wu Z; Jiang D; Hsieh CY; Chen G; Liao B; Cao D; Hou T
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones.
    Amini Z; Fatemi MH; Gharaghani S
    Comput Biol Chem; 2016 Oct; 64():335-345. PubMed ID: 27570070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
    Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.